WA
PLXP

WFG Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

WFG Advisors’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$0 Buy
+12
New +$88 ﹤0.01% 1699
2017
Q1 		– Sell
-13
Closed – – 1707
2016
Q4 		$0 Buy
+13
New +$478 ﹤0.01% 1775

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HWA
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WFG Advisors's PLXP Position: Q2 2017 in Review

WFG Advisors opened a new position in PLx Pharma Inc. Common Stock (PLXP) in Q2 2017: 12 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1699 among its holdings. This is a return to the name: WFG Advisors previously reported a position in PLXP as recently as Q4 2016.

WFG Advisors first reported a position in PLXP in Q4 2016 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold PLXP as of Q2 2017.

  • WFG Advisors held 12 shares of PLx Pharma Inc. Common Stock worth $0 as of Q2 2017.
  • PLx Pharma Inc. Common Stock was a new WFG Advisors position in Q2 2017.
  • PLx Pharma Inc. Common Stock made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1699 holding.
  • WFG Advisors first reported a position in PLx Pharma Inc. Common Stock in Q4 2016 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.